Karen M. Boezi
Direktor/Vorstandsmitglied bei NaviNet, Inc.
Profil
Karen M.
Boezi is currently a Director at NaviNet, Inc., a Director at Acrigen Biosciences, Inc., and a Member-Industrial Advisory Board at the California Institute For Quantitative Biosciences.
Previously, she served as the Chief Executive Officer of Redwood Bioscience, Inc., a Director at Leptos Biomedical, Inc., and held the position of Principal at Warburg Pincus LLC from 1990 to 2003.
She also worked as an Analyst at Alex.
Brown & Sons, Inc. and as a Partner at Thomas, McNerney & Partners LLC.
Additionally, she was a General Partner at Coral Group, Inc. from 1994 to 2009.
Ms. Boezi obtained her undergraduate degree from The Wharton School of the University of Pennsylvania.
Aktive Positionen von Karen M. Boezi
Unternehmen | Position | Beginn |
---|---|---|
NaviNet, Inc.
NaviNet, Inc. Packaged SoftwareTechnology Services NaviNet, Inc. provides software for communication between healthcare providers. It offers NaviNet open provider portal, open advance referrals, document exchange and value based network applications. The company was founded in 1998 by Robert Chin, Thomas G. Morrison, William R. Cowen, Bradley J. Waugh and Jeffrey Daly and is headquartered in Boston, MA. | Direktor/Vorstandsmitglied | 15.09.2011 |
California Institute For Quantitative Biosciences
California Institute For Quantitative Biosciences Investment ManagersFinance Part of University of California, California Institute For Quantitative Biosciences is a biotech company that offers internships to UC students through its state-funded Qwest internship program. The company is based in San Francisco, CA and was founded in 2000. The program places students with Bakar Labs tenant companies for work experience, and four of its first cohort have already received full-time job offers from their hosts. The company conducts proof-of-concept experiments in a mouse model of ALS and offers mentoring programs to early-stage companies. | Corporate Officer/Principal | 15.09.2011 |
Acrigen Biosciences, Inc.
Acrigen Biosciences, Inc. BiotechnologyHealth Technology Acrigen Biosciences, Inc. operates as a early-stage life science gene editing company. The company was founded by Joseph Bondy-Denomy in 2019 and is headquartered in Kensington, CA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Karen M. Boezi
Unternehmen | Position | Ende |
---|---|---|
Leptos Biomedical, Inc.
Leptos Biomedical, Inc. Medical SpecialtiesHealth Technology Leptos is developing a proprietary neuromodulation therapy for chronic obesity. The treatment, delivered via a pacemaker-type device, involves electrical activation of a specific nerve in the autonomic nervous system. They believe that this therapy may offer an effective minimally invasive, reversible surgical option for people suffering from chronic obesity. As yet, the Leptos therapy is not approved for sale in the United States and is limited to investigational use. | Direktor/Vorstandsmitglied | 12.11.2010 |
Thomas, McNerney & Partners LLC
Thomas, McNerney & Partners LLC Investment ManagersFinance Thomas, McNerney & Partners LLC (Thomas McNerney & Partner) is a venture capital subsidiary of the Coral Group Inc founded in 1998. The firm is headquartered in Minneapolis, Minnesota. | Private Equity Investor | 31.07.2009 |
Coral Group, Inc.
Coral Group, Inc. Investment ManagersFinance Coral Group, Inc. is a venture capital firm. It offers telecom, Internet and media content, real time data, IoT sectors, mobile, security, ecommerce, and cloud services. The company was founded by Yuval Almog in 1990 and is headquarterd in Minneapolis, MN. | Corporate Officer/Principal | 17.02.2009 |
Warburg Pincus LLC
Warburg Pincus LLC Investment ManagersFinance Warburg Pincus LLC (Warburg Pincus) is a private equity subsidiary of Warburg Pincus & Company US LLC founded in 1966. The firm is headquartered in New York. | Private Equity Investor | 31.12.2003 |
Redwood Bioscience, Inc.
Redwood Bioscience, Inc. BiotechnologyHealth Technology Redwood Bioscience Inc. develops precision protein-chemical engineering technology to produce the next-generation of antibody-drug conjugates and other semi-synthetic biotherapeutics. It employs natural post translational modifications found in human cells to site specifically create one or more aldehyde tags on protein molecules, including monoclonal antibodies. The firm's platform is enabled with precision chemistries, payload positioning and defined stoichiometry of payload protein ratios. The company was founded by Carolyn R. Bertozzi, Mike Blank and David Rabuka in 2008 and is headquartered in Emeryville, CA. | Vorstandsvorsitzender | - |
Ausbildung von Karen M. Boezi
The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 9 |
---|---|
Thomas, McNerney & Partners LLC
Thomas, McNerney & Partners LLC Investment ManagersFinance Thomas, McNerney & Partners LLC (Thomas McNerney & Partner) is a venture capital subsidiary of the Coral Group Inc founded in 1998. The firm is headquartered in Minneapolis, Minnesota. | Finance |
Coral Group, Inc.
Coral Group, Inc. Investment ManagersFinance Coral Group, Inc. is a venture capital firm. It offers telecom, Internet and media content, real time data, IoT sectors, mobile, security, ecommerce, and cloud services. The company was founded by Yuval Almog in 1990 and is headquarterd in Minneapolis, MN. | Finance |
Warburg Pincus LLC
Warburg Pincus LLC Investment ManagersFinance Warburg Pincus LLC (Warburg Pincus) is a private equity subsidiary of Warburg Pincus & Company US LLC founded in 1966. The firm is headquartered in New York. | Finance |
Alex. Brown & Sons, Inc. | Finance |
Leptos Biomedical, Inc.
Leptos Biomedical, Inc. Medical SpecialtiesHealth Technology Leptos is developing a proprietary neuromodulation therapy for chronic obesity. The treatment, delivered via a pacemaker-type device, involves electrical activation of a specific nerve in the autonomic nervous system. They believe that this therapy may offer an effective minimally invasive, reversible surgical option for people suffering from chronic obesity. As yet, the Leptos therapy is not approved for sale in the United States and is limited to investigational use. | Health Technology |
Redwood Bioscience, Inc.
Redwood Bioscience, Inc. BiotechnologyHealth Technology Redwood Bioscience Inc. develops precision protein-chemical engineering technology to produce the next-generation of antibody-drug conjugates and other semi-synthetic biotherapeutics. It employs natural post translational modifications found in human cells to site specifically create one or more aldehyde tags on protein molecules, including monoclonal antibodies. The firm's platform is enabled with precision chemistries, payload positioning and defined stoichiometry of payload protein ratios. The company was founded by Carolyn R. Bertozzi, Mike Blank and David Rabuka in 2008 and is headquartered in Emeryville, CA. | Health Technology |
NaviNet, Inc.
NaviNet, Inc. Packaged SoftwareTechnology Services NaviNet, Inc. provides software for communication between healthcare providers. It offers NaviNet open provider portal, open advance referrals, document exchange and value based network applications. The company was founded in 1998 by Robert Chin, Thomas G. Morrison, William R. Cowen, Bradley J. Waugh and Jeffrey Daly and is headquartered in Boston, MA. | Technology Services |
California Institute For Quantitative Biosciences
California Institute For Quantitative Biosciences Investment ManagersFinance Part of University of California, California Institute For Quantitative Biosciences is a biotech company that offers internships to UC students through its state-funded Qwest internship program. The company is based in San Francisco, CA and was founded in 2000. The program places students with Bakar Labs tenant companies for work experience, and four of its first cohort have already received full-time job offers from their hosts. The company conducts proof-of-concept experiments in a mouse model of ALS and offers mentoring programs to early-stage companies. | Finance |
Acrigen Biosciences, Inc.
Acrigen Biosciences, Inc. BiotechnologyHealth Technology Acrigen Biosciences, Inc. operates as a early-stage life science gene editing company. The company was founded by Joseph Bondy-Denomy in 2019 and is headquartered in Kensington, CA. | Health Technology |